Ryman Healthcare

Rising Interest Rates And Policy Risks Will Hamper Aged Care

AnalystLowTarget

Not Invested

Community Contributor

Published

22 Aug 25

AnalystLowTarget's Fair Value

NZ$2.51

9.2% overvalued

22 Aug

NZ$2.74

-44.1%

-5.2%

-44.1%

-5.2%

You can edit this narrative until Aug 22 10:16 PM. Then, changes will post as Updates.

Author's Valuation

NZ$2.519.2% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

NZ$2.51

9.2% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

7.05%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.00%

Calculation

NZ$487.86m

Earnings '28

7.81x

PE Ratio '28

NZ$3.81b

Market Cap '28

NZ$3.81b

Market Cap '28

1.24b

No. shares '28

NZ$3.07

Share Price '28

NZ$3.07 Share Price '28

Discounted to 2025 @ 6.93% p.a.

NZ$2.51

Fair Value '25